{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:37:43Z","timestamp":1793889463559,"version":"4.8.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Mycology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.mycmed.2024.101476","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T17:35:57Z","timestamp":1710524157000},"page":"101476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Acquired resistance or tolerance? \u2013 in search of mechanisms underlying changes in the resistance profile of Candida albicans and Candida parapsilosis as a result of exposure to methotrexate"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1359-8879","authenticated-orcid":false,"given":"Katarzyna","family":"G\u00f3ralska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Szybka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6551-6804","authenticated-orcid":false,"given":"Filip Franciszek","family":"Karuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7602-9203","authenticated-orcid":false,"given":"Dorota","family":"Pastuszak-Lewandoska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0882-1458","authenticated-orcid":false,"given":"Ewa","family":"Brzezia\u0144ska-Lasota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mycmed.2024.101476_bib0001","article-title":"WHO fungal priority pathogens list to guide research, development and public health action","year":"2022","journal-title":"Geneva"},{"key":"10.1016\/j.mycmed.2024.101476_bib0002","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3390\/encyclopedia3030064","article-title":"Fungi in a one health perspective","volume":"3","author":"Simoes","year":"2023","journal-title":"Encyclopedia"},{"issue":"4","key":"10.1016\/j.mycmed.2024.101476_bib0003","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.15244\/pjoes\/162052","article-title":"Threats resulting from the presence of potentially pathogenic fungi in the sport changing rooms \u2013 a preliminary study","volume":"32","author":"Ba\u0142aba\u0144ski","year":"2023","journal-title":"Pol. J. Environ. Stud."},{"key":"10.1016\/j.mycmed.2024.101476_bib0004","doi-asserted-by":"crossref","first-page":"21408","DOI":"10.1038\/s41598-023-48598-0","article-title":"Evaluation of wahing machines as an extreme environment for potentially pathogenic fungi","volume":"13","author":"Zareshahrabadi","year":"2023","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.mycmed.2024.101476_bib0005","first-page":"159","article-title":"Interactions between potentially pathogenic fungi and natural microbiota","volume":"60","author":"G\u00f3ralska","year":"2014","journal-title":"Ann. of Parasit."},{"issue":"6","key":"10.1016\/j.mycmed.2024.101476_bib0006","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3390\/antibiotics9060312","article-title":"Candidiasis and mechanisms of antifungal resistance","volume":"9","author":"Bhattacharya","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.mycmed.2024.101476_bib0007","doi-asserted-by":"crossref","first-page":"946","DOI":"10.3390\/jof8090946","article-title":"The changing landscape of invasive fungal infections in ICUs: a need for risk stratification to better target antifungal drugs and the threat of resistance","volume":"8","author":"Poissy","year":"2022","journal-title":"J. Fungi"},{"key":"10.1016\/j.mycmed.2024.101476_bib0008","unstructured":"Index Fungorum. Available online http:\/\/www.indexfungorum.org (accessed on 20th October 2023)."},{"issue":"1","key":"10.1016\/j.mycmed.2024.101476_bib0009","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac559","article-title":"Fungal nomenclature: managing change is the name of the game","volume":"10","author":"Kidd","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.mycmed.2024.101476_bib0010","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.3389\/fmicb.2016.02173","article-title":"Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species","volume":"7","author":"Whaley","year":"2017","journal-title":"Front. Microbiol."},{"issue":"12","key":"10.1016\/j.mycmed.2024.101476_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2022.08.014","article-title":"Clinical azole cross-resistance in Candida parapsilosis is related to a novel MRR1 gain-of-function mutation","volume":"28","author":"Branco","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.mycmed.2024.101476_bib0012","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3390\/jof9010080","article-title":"Candida parapsilosis virulence and antifungal resistance mechanisms: a comprehensive review of key determinants","volume":"5","author":"Branco","year":"2023","journal-title":"J Fungi (Basel)"},{"issue":"6","key":"10.1016\/j.mycmed.2024.101476_bib0013","doi-asserted-by":"crossref","first-page":"e470","DOI":"10.1016\/S2666-5247(23)00067-8","article-title":"Worldwide emergence of fluconazole-resistant Candida parapsilosis: current framework and future research roadmap","volume":"4","author":"Daneshnia","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.mycmed.2024.101476_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2023.08.001","article-title":"European candidaemia is characterised by notable differential epidemiology and susceptibility pattern; Results from the ECMM Candida III study","author":"Arendrup","year":"2023","journal-title":"J Infect"},{"issue":"3","key":"10.1016\/j.mycmed.2024.101476_bib0015","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/jof4030097","article-title":"Treatment of invasive candidiasis: a narrative review","volume":"16","author":"Ben-Ami","year":"2018","journal-title":"J Fungi (Basel)"},{"issue":"12","key":"10.1016\/j.mycmed.2024.101476_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010073","article-title":"Fungicide effects on human fungal pathogens: cross-resistance to medical drugs and beyond","volume":"17","author":"Bastos","year":"2021","journal-title":"PLoS Pathog"},{"issue":"4","key":"10.1016\/j.mycmed.2024.101476_bib0017","doi-asserted-by":"crossref","first-page":"789","DOI":"10.13005\/bbra\/2884","article-title":"Azoles used in agriculture as possible cause of azole-resistance in clinical Candida isolates","volume":"17","author":"Kaur","year":"2020","journal-title":"Bisci. Biotech. Res. Asia."},{"key":"10.1016\/j.mycmed.2024.101476_bib0018","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41579-022-00720-1","article-title":"Tackling the emerging threat of antifungal resistance to human health","volume":"20","author":"Fisher","year":"2022","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.mycmed.2024.101476_bib0019","unstructured":"EUCAST. 2020. The European committee on antimicrobial susceptibility testing. breakpoint tables for interpretation of MICs for antifungal agents. version 10.0, 2020. https:\/\/www.eucast.org\/astoffungi\/clinicalbreakpointsforantifungals\/."},{"issue":"10","key":"10.1016\/j.mycmed.2024.101476_bib0020","first-page":"B5288","article-title":"Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment","volume":"63","author":"Jensen","year":"2016","journal-title":"Dan Med J"},{"key":"10.1016\/j.mycmed.2024.101476_bib0021","first-page":"e18025","article-title":"Multidrug-resistant Candida glabrata strains obtained by induction of anidulafungin resistance in planktonic and biofilm cells. Braz","volume":"55","author":"Hatwig","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.mycmed.2024.101476_bib0022","first-page":"11","article-title":"Emerging threats in antifungal-resistant fungal pathogens","volume":"3","author":"Sanglard","year":"2016","journal-title":"Front Med (Lausanne)"},{"issue":"suppl_3","key":"10.1016\/j.mycmed.2024.101476_bib0023","doi-asserted-by":"crossref","first-page":"S445","DOI":"10.1093\/infdis\/jix131","article-title":"Multidrug-resistant candida: epidemiology, molecular mechanisms, and treatment","volume":"216","author":"Arendrup","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mycmed.2024.101476_bib0024","doi-asserted-by":"crossref","first-page":"566","DOI":"10.5586\/am.566","article-title":"Detection of cross-resistance between methotrexate and azoles in Candida albicans and Meyerozyma guilliermondii: an in vitro study","volume":"56","author":"Karuga","year":"2021","journal-title":"Acta Mycol"},{"issue":"12","key":"10.1016\/j.mycmed.2024.101476_bib0025","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1128\/EC.00137-15","article-title":"The ABCs of Candida albicans multidrug transporter Cdr1","volume":"14","author":"Prasad","year":"2015","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.mycmed.2024.101476_bib0026","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/1756-185X.12362","article-title":"Multidrug resistance protein-1 expression, function and polymorphisms in patients with rheumatoid arthritis not responding to methotrexate","volume":"17","author":"Prasad","year":"2014","journal-title":"Int J Rheum Dis"},{"issue":"10","key":"10.1016\/j.mycmed.2024.101476_bib0027","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1128\/AAC.00344-11","article-title":"The quorum-sensing molecule farnesol is a modulator of drug efflux mediated by ABC multidrug transporters and synergizes with drugs in Candida albicans","volume":"55","author":"Sharma","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.mycmed.2024.101476_bib0028","first-page":"e29518","article-title":"Overview of methotrexate toxicity: a comprehensive literature review","volume":"14","author":"Hamed","year":"2022","journal-title":"Cureus"},{"issue":"235","key":"10.1016\/j.mycmed.2024.101476_bib0029","article-title":"In vitro synergy of azole antifungals and methotrexate against Candida albicans","volume":"15","author":"Yang","year":"2019","journal-title":"Life Sci"},{"key":"10.1016\/j.mycmed.2024.101476_bib0030","article-title":"Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts","author":"Arendrup","year":"2020","journal-title":"EUCAST E.DEF"},{"key":"10.1016\/j.mycmed.2024.101476_bib0031","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2-\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.mycmed.2024.101476_bib0032","first-page":"076","article-title":"Antifungal resistance of Candida species in Bacolod City","volume":"5","author":"Juayang","year":"2019","journal-title":"Philippines. J Infect Dis Epidemiol"},{"issue":"4","key":"10.1016\/j.mycmed.2024.101476_bib0033","doi-asserted-by":"crossref","first-page":"134","DOI":"10.55133\/eji.290413","article-title":"Detection of ERG11 gene in fluconazole resistant urinary candida isolates","volume":"29","author":"El-Said","year":"2022","journal-title":"Egypt J Immunol"},{"key":"10.1016\/j.mycmed.2024.101476_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/ffunb.2022.1010782","article-title":"Fluconazole-resistant Candida parapsilosis: a new emerging threat in the fungi arena","volume":"3","author":"Escribano","year":"2022","journal-title":"Front. Fungal Bio."},{"issue":"3","key":"10.1016\/j.mycmed.2024.101476_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.resmic.2022.104025","article-title":"High-throughput functional profiling of the human fungal pathogen Candida albicans genome","volume":"174","author":"Chauvel","year":"2023","journal-title":"Res. Microbiol."},{"issue":"12","key":"10.1016\/j.mycmed.2024.101476_bib0036","doi-asserted-by":"crossref","DOI":"10.5812\/jjm.120801","article-title":"Changing trends of candida species and antifungal susceptibility profile of Candida bloodstream isolates: a 5-year retrospective survey","volume":"14","author":"Yardimci","year":"2021","journal-title":"Jundishapur J Microbiol"},{"key":"10.1016\/j.mycmed.2024.101476_bib0037","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2147\/IDR.S118892","article-title":"Fluconazole resistance in Candida species: a current perspective","volume":"10","author":"Berkow","year":"2017","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.mycmed.2024.101476_bib0038","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3390\/jof9080798","article-title":"Candida parapsilosis sensu stricto antifungal resistance mechanisms and associated epidemiology","volume":"9","author":"Franconi","year":"2023","journal-title":"J. Fungi"},{"key":"10.1016\/j.mycmed.2024.101476_bib0039","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.3390\/antibiotics10111302","article-title":"Does systemic methotrexate therapy induce azole resistance among endogenous Candida strains?","volume":"10","author":"\u017byrek","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.mycmed.2024.101476_bib0040","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12866-022-02564-4","article-title":"Investigation of fluconazole susceptibility to Candida albicans by MALDI-TOF MS and real-time PCR for CDR1, CDR2, MDR1 and ERG11","volume":"22","author":"Maenchantrarath","year":"2022","journal-title":"BMC Microbiol"},{"issue":"10","key":"10.1016\/j.mycmed.2024.101476_bib0041","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.1128\/AAC.01358-15","article-title":"Multidrug transporters and alterations in sterol biosynthesis contribute to azole antifungal resistance in Candida parapsilosis","volume":"59","author":"Berkow","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.mycmed.2024.101476_bib0042","doi-asserted-by":"crossref","first-page":"275","DOI":"10.18869\/acadpub.ibj.21.4.275","article-title":"Regulation of ERG3, ERG6, and ERG11 genes in antifungal-resistant isolates of Candida parapsilosis","volume":"21","author":"Lotfali","year":"2017","journal-title":"Iran Biomed J"},{"issue":"3","key":"10.1016\/j.mycmed.2024.101476_bib0043","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00374-20","article-title":"Dihydrofolate reductase is a valid target for antifungal development in the human pathogen Candida albicans","volume":"5","author":"DeJarnette","year":"2020","journal-title":"mSphere"}],"container-title":["Journal of Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523324000179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523324000179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T07:55:39Z","timestamp":1717314939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523324000179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1156523324000179"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2024.101476","relation":{},"ISSN":["1156-5233"],"issn-type":[{"value":"1156-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acquired resistance or tolerance? \u2013 in search of mechanisms underlying changes in the resistance profile of Candida albicans and Candida parapsilosis as a result of exposure to methotrexate","name":"articletitle","label":"Article Title"},{"value":"Journal of Medical Mycology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2024.101476","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS on behalf of SFMM.","name":"copyright","label":"Copyright"}],"article-number":"101476"}}